🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Assessment of COVID-19 with complications post acute phase. Read the full study from Eric YF Wan Irene Zhang Sukriti Mathur Vincent Yan Francisco TT Lai Celine Chui HKU Shirley Xue Li Carlos KH Wong Esther Chan @ CSMPR HKU Prof Ian Wong and colleagues here: bmcmedicine.biomedcentral.com/articles/10.11…

Study in BMC Medicine showed the significant increased risk of multiple disease outcomes with increasing severity in both acute and post-acute phases of #Covid_19 infection, especially among elderly population. doi.org/10.1186/s12916…

Our study in BMC Medicine showed a significant increase in the risk of multiple disease outcomes associated with the severity of COVID-19 infection, both during the acute and post-acute phases. bmcmedicine.biomedcentral.com/articles/10.11…

Happy to share the 1st 1st-author PhD publication by my 1st RPg student Yuqi Hu! Published in PLOS Medicine, findings demonstrate an elevated but rather rare risk of hematological malignancy associated with clozapine use #Cancer #schizophrenia dx.plos.org/10.1371/journa…

Our focus group study qualitatively identified the barriers to medication adherence and the factors influencing the choice of lipid-lowering agents among patients with hypercholesterolemia in Hong Kong. tandfonline.com/doi/full/10.10…

Our study in CancerMedicine showed an increased risks of CVDs and mortality in cancer patients. onlinelibrary.wiley.com/doi/10.1002/ca…

Long-Term Benefits and Safety of Statins in Patients with... : Journal of the American Society of Nephrology journals.lww.com/jasn/abstract/…

Our study in Nature Communications found an increased risk of myasthenia gravis six months after statin initiation, but no heightened risk during the following 18 months. doi.org/10.1038/s41467…

Our last but not least paper about Covid published at BMJ Public Health - re-infection posed greater risk for hospitalization and mortality compared with first-time infection. Prevention is the still the key ⁦CSMPR_HKU⁩ ⁦Vincent Yan⁩ bmjpublichealth.bmj.com/content/3/1/e0…

Our recent research letter found increasing use of biosimilars in Hong Kong in the last 12 years; while oral tsDMARDs remain the highest retention among patients with rheumatoid arthritis. Great team work from colleagues PhD and MBBS students at HKUMed. onlinelibrary.wiley.com/doi/10.1111/17…

Our The Lancet Healthy Longevity study finds that #Statin therapy is beneficial for #hypercholesterolemic patients with chronic #kidney disease aged 75+ against #CVD and all-cause #mortality, without posing an increased risk of major adverse events. thelancet.com/journals/lanhl…

Delighted to share this new paper led by my PhD student Claire Cuiling WEI, investigating rates and rate ratio of multimorbidity incidence after SARS- or influenza-related admissions. Findings now available in npj Journals Prim Care Respir Med by PCRS nature.com/articles/s4153…

Our latest work observed comparable survival benefit but significant lower health resource utilization associated with novel hormonal agents when comparing to docetaxel for the management of prostate cancer. Published at ⁦iScience journal⁩ Cell Press. sciencedirect.com/science/articl…

Our study used cohort and case-crossover design to investigate the risk of gastrointestinal bleeding associated with combined use of oral anticoagulants and proton pump inhibitors using UK and HK data. Findings published in npj Journals nature.com/articles/s4432…

Country Income, Gini Index, Disease Burden and Universal Health Coverage, which one you would expect as the driving factor for the access of WHO essential cancer medicine? Read our fresh online paper on Lancet Oncology.sciencedirect.com/science/articl… HKU Medicine HKU Pharmacy CSMPR_HKU

Our study investigated the #COVID19 pandemic effects on #CVD incidence among #hypertensive patients without SARS-CoV-2 infection by changes in CVD incidence, all-cause #mortality, #BP control, and healthcare utilization rates among this population in HK. nature.com/articles/s4144…

Our study, the largest conducted to date examining various classes of antihypertensive drugs and dementia risk. We found a lower risk of all-cause dementia with ARBs compared to ACE inhibitors. Hong Kong, UK, Sweden, and Australia data included. doi.org/10.1093/ageing…

Letter written with Dr Angel Wong on bias in a study of PCSK9 inhibitors. Read it in European Heart Journal - Cardiovascular Pharmacotherapy academic.oup.com/ehjcvp/advance… HKU Medicine @hkupharm @csmpr_hkupharm #epidemiology #lipids #pharmacotherapy #cardiology

Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with Springer Nature in Communications Medicine Read here: rdcu.be/eocfU Prof Ian Wong Celine Chui HKU Kenneth Man Martin Knapp Gloria Wong